Expert NetworkExpert InterviewKPTI

Slingshot members are talking to an expert! The topic is:

A second view: Discussing the ASCO 2022 poster "A phase 1, open-label, dose-escalation study of selinexor plus ruxolitinib in patients with treatment-naïve myelofibrosis" from Karyopharm Therapeutics

Executed on:Apr 13, 2023 2:30 PM EDT
Call Duration:30 minutes

Expert Profile

ExpertBlinded Expert
Institution: Vanderbilt University Medical Center
  • Assistant Professor of Medicine, Hematology/Oncology at Vanderbilt University Medical Center
  • Manages 60 patients with Myelofibrosis and 10+ with CML
  • Completed fellowship in experimental therapeutics from Taussig Cancer institute in 2021 and research focuses on cancer biology

Interview Goal

To discuss the existing data, and expectations from the updated results to be presented at AACR

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.